Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair

Laboratory Investigation

Volumn 96, Issue 4, 2016, Pages 439-449

  Crompton, Rachel ^a   Williams, Helen ^a   Ansell, David ^a   Campbell, Laura ^a   Holden, Kirsty ^b   Cruickshank, Sheena ^a   Hardman, Matthew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Epistem Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ESTRADIOL; ESTROGEN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EPITHELIZATION; FEMALE; INFLAMMATION; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HOST PATHOGEN INTERACTION; HUMAN; KERATINOCYTE; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; TIME FACTOR;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; KERATINOCYTES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; SKIN; TIME FACTORS; TOLL-LIKE RECEPTOR 4; WOUND HEALING; WOUND INFECTION;

EID: 84962318237     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.160     Document Type: Article

References (76)

1. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-214.
2. Harder J, Bartels J, Christophers E et al. A peptide antibiotic from human skin. Nature 1997;387:861.
3. Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. Science 2014;346:954-959.
4. Gontcharova V, Youn E, Sun Y et al. A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J 2010;4:8-19.
5. Martin JM, Zenilman JM, Lazarus GS. Molecular microbiology: new dimensions for cutaneous biology and wound healing. J Invest Dermatol 2010;130:38-48.
6. Hart J. Inflammation. 2: Its role in the healing of chronic wounds. J Wound Care 2002;11:245-249.
7. Custovic A, Smajlovic J, Hadzic S et al. Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Mater Sociomed 2014;26:7-11.
8. Calhoun JH, Murray CK, Manring MM. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 2008;466:1356-1362.
9. Petersen K, Riddle MS, Danko JR et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007;245:803-811.
10. Yun HC, Murray CK, Roop SA et al. Bacteria recovered from patients admitted to a deployed U. S. military hospital in Baghdad, Iraq. Mil Med 2006;171:821-825.
11. Weintrob AC, Roediger MP, Barber M et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010;31:330-337.
12. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003;37:543-550.
13. Oates A, Bowling FL, Boulton AJ et al. Molecular and culture-based assessment of the microbial diversity of diabetic chronic foot wounds and contralateral skin sites. J Clin Microbiol 2012;50:2263-2271.
14. Wysocki AB, Bhalla-Regev SK, Tierno Jr PM et al. Proteolytic activity by multiple bacterial species isolated from chronic venous leg ulcers degrades matrix substrates. Biol Res Nurs 2013;15:407-415.
15. Yoga R, Khairul A, Sunita K et al. Bacteriology of diabetic foot lesions. Med J Malaysia 2006;61(Suppl A):14-16.
16. Varaiya AY, Dogra JD, Kulkarni MH et al. Extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infections. Indian J Pathol Microbiol 2008;51:370-372.
17. Pukstad BS, Ryan L, Flo TH et al. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. J Dermatol Sci 2010;59:115-122.
18. Schierle CF, De la Garza M, Mustoe TA et al. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;17:354-359.
19. Scales BS, Huffnagle GB. The microbiome in wound repair and tissue fibrosis. J Pathol 2013;229:323-331.
20. Zhao G, Usui ML, Lippman SI et al. Biofilms and inflammation in chronic wounds. Adv Wound Care (New Rochelle) 2013;2:389-399.
21. Bosanquet DC, Harding KG. Wound duration and healing rates: cause or effect Wound Repair Regen 2014;22:143-150.
22. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008;10:44-53.
23. Mills Sr JL, Conte MS, Armstrong DG et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220-234.
24. Kumar S, Ingle H, Prasad DV et al. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol 2013;39:229-246.
25. Kawai K, Shimura H, Minagawa M et al. Expression of functional Tolllike receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002;30:185-194.
26. Wang J, Hori K, Ding J et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol 2011;226: 1265-1273.
27. West AP, Brodsky IE, Rahner C et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476-480.
28. Dasu MR, Martin SJ. Toll-like receptor expression and signaling in human diabetic wounds. World J Diabetes 2014;5:219-223.
29. Lin Q, Fang D, Fang J et al. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice. J Immunol 2011;186:3710-3717.
30. Sato T, Yamamoto M, Shimosato T et al. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen 2010;18:586-593.
31. Campbell L, Williams H, Crompton RA et al. Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response. J Pathol 2013;229:121-131.
32. Macedo L, Pinhal-Enfield G, Alshits V et al. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 2007;171: 1774-1788.
33. Dasu MR, Thangappan RK, Bourgette A et al. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest 2010;90:1628-1636.
34. Lin Q, Wang L, Lin Y et al. Toll-like receptor 3 ligand polyinosinic: polycytidylic acid promotes wound healing in human and murine skin. J Invest Dermatol 2012;132:2085-2092.
35. Konturek PC, Brzozowski T, Konturek SJ et al. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol 2001;36:1239-1247.
36. Brothers KM, Stella NA, Hunt KM et al. Putting on the brakes: Bacterial impediment of wound healing. Sci Rep 2015;5:14003.
37. Stifano G, Affandi AJ, Mathes AL et al. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther 2014;16:R136.
38. Ishikawa Y, Kirikae T, Hirata M et al. Local skin response in mice induced by a single intradermal injection of bacterial lipopolysaccharide and lipid A. Infect Immun 1991;59:1954-1960.
39. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - A review of laboratory models and a proposal. J Surg Res 1980;29: 189-201.
40. Suga H, Sugaya M, Fujita H et al. TLR4, rather than TLR2, regulates wound healing through TGF-beta and CCL5 expression. J Dermatol Sci 2014;73:117-124.
41. Chen L, Guo S, Ranzer MJ et al. Toll-like receptor 4 plays an essential role in early skin wound healing. J Invest Dermatol 2013;133:258-267.
42. Singh K, Singh VK, Agrawal NK et al. Association of Toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. Biomed Res Int 2013;2013.
43. Ansell DM, Holden KA, Hardman MJ. Animal models of wound repair: are they cutting it Exp Dermatol 2012;21:581-585.
44. Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002;359: 675-677.
45. Ashcroft GS, Greenwell-Wild T, Horan MA et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999;155:1137-1146.
46. Emmerson E, Campbell L, Ashcroft GS et al. Unique and synergistic roles for 17beta-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific. Endocrinology 2009;150:2749-2757.
47. Mukai K, Nakajima Y, Urai T et al. 17beta-Estradiol administration promotes delayed cutaneous wound healing in 40-week ovariectomised female mice. Int Wound J 2014, Aug 6. doi:10. 1111/iwj. 12336. [e-pub ahead of print], PMID: 25132513.
48. Ansell DM, Campbell L, Thomason HA et al. A statistical analysis of murine incisional and excisional acute wound models. Wound Repair Regen 2014;22:281-287.
49. Ashida H, Mimuro H, Ogawa M et al. Cell death and infection: a doubleedged sword for host and pathogen survival. J Cell Biol 2011;195: 931-942.
50. Ferluga J, Allison AC. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 1978;2:610-611.
51. Peavy DL, Baughn RE, Musher DM. Strain-dependent cytotoxic effects of endotoxin for mouse peritoneal macrophages. Infect Immun 1978;21:310-319.
52. Rieger S, Zhao H, Martin P et al. The role of nuclear hormone receptors in cutaneous wound repair. Cell Biochem Funct 2015;33:1-13.
53. Grice EA, Segre JA. Interaction of microbiome and the innate immune response in chronic wounds. Adv Exp Med Biol 2012;946:55-68.
54. Dowd SE, Sun Y, Secor PR et al. Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
55. Park BK, Kim D, Cho S et al. Effects of lipopolysaccharide and CpG-DNA on burn-induced skin injury. BMB Rep 2011;44:273-278.
56. Ami K, Kinoshita M, Yamauchi A et al. IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18. J Immunol 2002;169:4437-4442.
57. Kawaguchi H, Hizuta A, Tanaka N et al. Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol 1995;89: 317-327.
58. Koff JL, Shao MX, Kim S et al. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J Immunol 2006;177:8693-8700.
59. Loryman C, Mansbridge J. Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen 2008;16:45-51.
60. Kirker KR, Secor PR, James GA et al. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009;17:690-699.
61. Kostarnoy AV, Gancheva PG, Logunov DY et al. Topical bacterial lipopolysaccharide application affects inflammatory response and promotes wound healing. J Interferon Cytokine Res 2013;33:514-522.
62. Morasso MI, Tomic-Canic M. Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing. Biol Cell 2005;97:173-183.
63. Pastar I, Stojadinovic O, Yin NC et al. Epithelialization in wound healing: a comprehensive review. Adv Wound Care (New Rochelle) 2014;3: 445-464.
64. Lessard JC, Piña-Paz S, Rotty JD et al. Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci USA 2013;110:19537-19542.
65. Tie L, An Y, Han J et al. Genistein accelerates refractory wound healing by suppressing superoxide and FoxO1/iNOS pathway in type 1 diabetes. J Nutr Biochem 2013;24:88-96.
66. Pincus DJ, Kassira N, Gombosh M et al. 17-Estradiol modifies diabetic wound healing by decreasing matrix metalloproteinase activity. Wounds 2010;22:171-178.
67. Toutain CE, Brouchet L, Raymond-Letron I et al. Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network. Circ Res 2009;104:245-254.
68. Gatson JW, Maass DL, Simpkins JW et al. Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J Neuroinflammation 2009;6:30.
69. Yao X, Wigginton JG, Maass DL et al. Estrogen-provided cardiac protection following burn trauma is mediated through a reduction in mitochondria-derived DAMPs. Am J Physiol Heart Circ Physiol 2014;306:H882-H894.
70. Brown CM, Mulcahey TA, Filipek NC et al. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 2010;151:4916-4925.
71. Zhou GJ, Zhang H, Zhi SD et al. Protective effect of raloxifene on lipopolysaccharide and acid-induced acute lung injury in rats. Acta Pharmacol Sin 2007;28:1585-1590.
72. Li X, Xu T, Lian Q et al. Protective effect of genistein on lipopolysaccharide-induced acute lung injury in rats. J Huazhong Univ Sci Technol Med Sci 2005;25:454-457.
73. Moeinpour F, Choudhry MA, Kawasaki T et al. 17 Beta-estradiol normalizes Toll receptor 4, mitogen activated protein kinases and inflammatory response in epidermal keratinocytes following traumahemorrhage. Mol Immunol 2007;44:3317-3323.
74. Emmerson E, Campbell L, Ashcroft GS et al. The phytoestrogen genistein promotes wound healing by multiple independent mechanisms. Mol Cell Endocrinol 2010;321:184-193.
75. Campbell L, Emmerson E, Davies F et al. Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities. J Exp Med 2010;207:1825-1833.
76. Seth AK, Geringer MR, Hong SJ et al. In vivo modeling of biofilminfected wounds: a review. J Surg Res 2012;178:330-338.